Labcorp Holdings Inc. to Announce Fourth Quarter Financial Results

Labcorp price target raised to $313 from $307 at Baird

Baird Adjusts Labcorp Price Target to $313 From $307, Maintains Outperform Rating

Labcorp Holdings Maintains Quarterly Dividend of $0.72 a Share, Payable March 12 to Shareholders of Record as of Feb. 27

Labcorp Holdings Inc. declares $0.72 per share quarterly dividend

Labcorp Declares Quarterly Dividend

Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Labcorp Expands Plasma Detect Portfolio to Enhance Early Cancer Recurrence Detection

Labcorp Expands Mrd Testing for Breast, Lung and Colon Cancer Recurrence Risk

Labcorp Holdings Inc. Files Initial Statement of Beneficial Ownership for Jonathan C. Meltzer, EVP of Operations

Labcorp Holdings Inc. Files Initial Statement of Beneficial Ownership for Bryan T. Vaughn, EVP of Diagnostics

Clinical Labs Hope to Head Off Looming Medicare Cuts -- Barrons.com

BRIEF-Visby Engages Quest And Labcorp To Broaden Consumer Access To First At-Home, FDA-Authorized Pcr Test For Stis

Labcorp to Offer Visby At-Home PCR STI Test Through Labcorp OnDemand

Visby Engages Quest and Labcorp to Broaden Consumer Access to First at-Home, FDA-Authorized Pcr Test for Stis

BRIEF-Namsa Announces Strategic Acquisition Of Select Assets Of The Early Development Medical Device Testing Business Of Labcorp

NAMSA Acquires Labcorp’s Early Development Medical Device Testing Business

Namsa Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp

Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading Day